On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
Bio-Rad Laboratories, Inc, a leading provider of life science research and clinical diagnostics solutions, has unveiled the ...
The Print on MSN14h
Remember pandemic, ASHA workers ask as protest for pay hike hits Day 32 amid Kerala-Centre blame gameASHA workers in Kerala are demanding a raise in their honorarium from current Rs 7,000 to Rs 21,000, a one-time retirement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback